Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. has successfully repurchased and subsequently cancelled 2,778,800 of its H shares, which is equivalent to 0.30% of its total issued share capital and 0.90% of its H shares. The repurchase operation saw shares bought at prices ranging from HK$23.05 to HK$26.15, with a total expenditure of HK$68.15 million, excluding transaction costs. Following the cancellation, the company’s registered capital has decreased accordingly, and it is taking steps to complete the necessary registration changes.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
